DARE vs XYL · rev $187.5K vs P/E 27, rev $4.46B
Dare Bioscience Inc (DARE) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported DARE revenue for 2026-06-30 was $187.5K. Net income was -$3.0M. Revenue was up 23.0% from 2026-03-31 to 2026-06-30. DARE currently screens at market cap $21.2M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
DARE currently screens at market cap $21.2M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the DARE and XYL stock pages for the full models.
Not investment advice.